Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Public sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 Biobanking industry 360º synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product and service trends
2.1.4 Sample type trends
2.1.5 Application trends
2.1.6 Storage type trends
2.1.7 End-user trends
Chapter 3 Biobanking Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Technological advancements in genomics, personalized medicine, and drug development
3.2.1.2 Increasing demand for personalized medicine
3.2.1.3 Increasing investments in genomic research
3.2.1.4 Integration of bioinformatics tools and advanced data analysis techniques
3.2.1.5 Increased need for cost-effective drug discovery and development
3.2.1.6 Growing investments and fundings for biobanks
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with automated systems
3.2.2.2 Issues related to biospecimen sample procurement
3.2.2.3 Data privacy and ethical concerns
3.2.2.4 High cost required for establishing and maintaining biobanks
3.2.2.5 Lack of incompatibility between different biobank data systems
3.3 Growth potential analysis
3.3.1 By product and service
3.3.2 By sample type
3.3.3 By application
3.3.4 By storage type
3.3.5 By end-user
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Biobanking Market, By Product and Service, 2018 - 2032 (USD Million)
5.1 Key trends, by products and service
5.2 Equipment
5.2.1 Storage equipment
5.2.2 Sample analysis equipment
5.2.3 Sample processing equipment
5.2.4 Sample transport equipment
5.3 Consumable
5.3.1 Storage consumables
5.3.2 Analysis consumables
5.3.3 Processing consumables
5.3.4 Collection consumables
5.4 Service
5.4.1 Storage services
5.4.2 Processing services
5.4.3 Transport services
5.4.4 Supply services
5.5 Software
Chapter 6 Biobanking Market, By Sample Type, 2018 – 2032 (USD Million)
6.1 Key trends, by sample type
6.2 Blood products
6.3 Human tissues
6.4 Cell lines
6.5 Nucleic acids
6.6 Biological fluids
6.7 Human waste products
Chapter 7 Biobanking Market, By Application, 2018 - 2032 (USD Million)
7.1 Key trends, by application
7.2 Regenerative medicine
7.3 Life-science research
7.4 Clinical research
Chapter 8 Biobanking Market, By Storage Type, 2018 - 2032 (USD Million)
8.1 Key trends, by storage type
8.2 Automated storage
8.3 Manual storage
Chapter 9 Biobanking Market, By End-user, 2018 - 2032 (USD Million)
9.1 Key trends, by end-user
9.2 Biotechnology & Pharmaceutical Companies
9.3 Contract research organizations (CROs)
9.4 Academic & Research Institutes
9.5 Hospitals
Chapter 10 Biobanking Market, By Region, 2018 - 2032 (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.2 PHC Holdings Corporation
11.3 Hamilton Company
11.4 Avantor Inc.
11.5 Qiagen N.V.
11.6 Tecan Trading AG
11.7 Merck & Co., Inc.
11.8 Becton, Dickinson and Company
11.9 Cryoport Inc.
11.10 Azenta Inc.
